The challenge of defining exacerbation in bronchiectasis

Miguel Ángel Martínez-García, Luis Máiz-Carro

Source: Eur Respir J, 49 (6) 1700700; 10.1183/13993003.00700-2017
Journal Issue: June
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Miguel Ángel Martínez-García, Luis Máiz-Carro. The challenge of defining exacerbation in bronchiectasis. Eur Respir J, 49 (6) 1700700; 10.1183/13993003.00700-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The challenge of acute exacerbation of pulmonary fibrosis
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014




The value of inflammation markers in acute infective exacerbations of bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 217s
Year: 2001

Defining the contribution of emphysema and chronic bronchitis in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 539s
Year: 2003

The biology of pulmonary exacerbations in bronchiectasis
Source: Eur Respir Rev, 28 (154) 190055; 10.1183/16000617.0055-2019
Year: 2019



The importance of eosinophilic inflammation in COPD exacerbations
Source: International Congress 2017 – COPD management
Year: 2017

The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019



The effect of bronchiectasis on asthma exacerbations
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012


The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009



Resolution of bronchial inflammation during exacerbations of chronic bronchitis relate to changes in bacteriology.
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002

The role of bronchial bacterial infection/colonization in acute exacerbation of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005

Bronchial challenge test in patients with chronic persistent cough and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 475s
Year: 2003

The character of COPD exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 34s
Year: 2006

Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 411s
Year: 2004

A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002



Defining severe bronchiectasis
Source: Eur Respir Monogr 2018; 81: 62-81
Year: 2018


PP301 – The role of the systemic inflammation in bronchiectasis exacerbation frequency
Source: ERS Lung Science Conference 2021
Year: 2021

Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?”
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


COPD and asthma overlap with bronchiectasis
Source: Eur Respir Monogr 2018; 81: 167-185
Year: 2018